GTBP
GT Biopharma·NASDAQ
--
--(--)
--
--(--)
1.00 / 10
Underperform
Technical score is 1.0, classified Underperform. Recent candlestick patterns show long upper and lower shadows, both bearish, with no bullish signals. The market appears weak, suggesting heightened downside risk.
Analysis Checks(0/2)
Long Upper Shadow
Score1/10
Win Rate41.94%
Hist. Signals62
Avg Return-1.70%
Score1/10
Win Rate41.94%
Hist. Signals62
Avg Return-1.70%
Long Lower Shadow
Score1/10
Win Rate41.33%
Hist. Signals75
Avg Return-1.91%
Score1/10
Win Rate41.33%
Hist. Signals75
Avg Return-1.91%
Long Upper Shadow
Score1/10
Win Rate41.94%
Hist. Signals62
Avg Return-1.70%
Score1/10
Win Rate41.94%
Hist. Signals62
Avg Return-1.70%
Long Lower Shadow
Score1/10
Win Rate41.33%
Hist. Signals75
Avg Return-1.91%
Score1/10
Win Rate41.33%
Hist. Signals75
Avg Return-1.91%
Technical Analysis of GTBP?
- GTBP presents a Underperform setup with a Technical Score of 1.00/10. Key technical indicators highlight an RSI of 38.63 and a MACD of 0.00, with the trend anchored by the 50-Day SMA at 0.50. Traders should monitor key support at 0.40 and resistance at 0.42.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
